Skip to main content
British Journal of Cancer logoLink to British Journal of Cancer
. 1994 Oct;70(4):743–748. doi: 10.1038/bjc.1994.388

Trends in tumour characteristics and survival of malignant melanoma 1960-84: a population-based study in Sweden.

M Thörn 1, F Pontén 1, R Bergström 1, P Sparén 1, H O Adami 1
PMCID: PMC2033418  PMID: 7917932

Abstract

In Sweden, improvement in survival rates of patients with cutaneous malignant melanoma has counteracted the increase in incidence to produce a moderate rise in mortality. Our aim was to determine the possible impact of drift in diagnostic criteria, earlier diagnosis and changing biological features of the tumours upon trends in survival. We studied a stratified sample of 528 patients diagnosed between 1960 and 1984 in a strictly defined geographical region. No evidence of drift in diagnostic criteria was found. The proportion of patients with invasion level Clark II increased from 3.2% in 1960-64 to 22.5% in 1980-84, the proportion of thin melanomas (< or = 0.75 mm) increased from 9.4% to 31.5% and the tumour thickness decreased significantly between each 5 year period of diagnosis. These changes are most likely the results of earlier diagnosis. However, changes in tumour characteristics have occurred, since the proportion of superficially spreading malignant melanoma increased from 35% in 1960-64 to 51% in 1980-84 and the proportion of acral lentiginous melanoma decreased from 11% to 2%. The proportion of nodular melanomas remained fairly constant. The proportion of tumours with lymphocytic reaction did not change, whereas those with histological regression increased slightly. Proportional hazards analyses showed a significantly lower survival in patients diagnosed in 1960-64 but no apparent trend after 1965. This finding remained after adjustment for all studied clinical and histopathological factors which point towards changes in unmeasured biological features of the disease.

Full text

PDF
743

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bagley F. H., Cady B., Lee A., Legg M. A. Changes in clinical presentation and management of malignant melanoma. Cancer. 1981 May 1;47(9):2126–2134. doi: 10.1002/1097-0142(19810501)47:9<2126::aid-cncr2820470904>3.0.co;2-c. [DOI] [PubMed] [Google Scholar]
  2. Balch C. M., Murad T. M., Soong S. J., Ingalls A. L., Halpern N. B., Maddox W. A. A multifactorial analysis of melanoma: prognostic histopathological features comparing Clark's and Breslow's staging methods. Ann Surg. 1978 Dec;188(6):732–742. doi: 10.1097/00000658-197812000-00004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Clark W. H., Jr, Elder D. E., Guerry D., 4th, Braitman L. E., Trock B. J., Schultz D., Synnestvedt M., Halpern A. C. Model predicting survival in stage I melanoma based on tumor progression. J Natl Cancer Inst. 1989 Dec 20;81(24):1893–1904. doi: 10.1093/jnci/81.24.1893. [DOI] [PubMed] [Google Scholar]
  4. Clark W. H., Jr, Elder D. E., Guerry D., 4th, Epstein M. N., Greene M. H., Van Horn M. A study of tumor progression: the precursor lesions of superficial spreading and nodular melanoma. Hum Pathol. 1984 Dec;15(12):1147–1165. doi: 10.1016/s0046-8177(84)80310-x. [DOI] [PubMed] [Google Scholar]
  5. Drzewiecki K. T., Frydman H., Andersen K., Poulsen H., Ladefoged C., Vibe P. Malignant melanoma. Changing trends in factors influencing metastasis-free survival from 1964 to 1982. Cancer. 1990 Jan 15;65(2):362–366. doi: 10.1002/1097-0142(19900115)65:2<362::aid-cncr2820650231>3.0.co;2-e. [DOI] [PubMed] [Google Scholar]
  6. Herberman R. B. Tumor immunology. JAMA. 1992 Nov 25;268(20):2935–2939. [PubMed] [Google Scholar]
  7. Holman C. D., James I. R., Gattey P. H., Armstrong B. K. An analysis of trends in mortality from malignant melanoma of the skin in Australia. Int J Cancer. 1980 Dec 15;26(6):703–709. doi: 10.1002/ijc.2910260602. [DOI] [PubMed] [Google Scholar]
  8. Houghton A., Flannery J., Viola M. V. Malignant melanoma in Connecticut and Denmark. Int J Cancer. 1980 Jan 15;25(1):95–104. doi: 10.1002/ijc.2910250113. [DOI] [PubMed] [Google Scholar]
  9. Jensen O. M., Bolander A. M. Trends in malignant melanoma of the skin. World Health Stat Q. 1980;33(1):2–26. [PubMed] [Google Scholar]
  10. Lederman J. S., Sober A. J. Does biopsy type influence survival in clinical stage I cutaneous melanoma? J Am Acad Dermatol. 1985 Dec;13(6):983–987. doi: 10.1016/s0190-9622(85)70249-6. [DOI] [PubMed] [Google Scholar]
  11. Little J. H., Holt J., Davis N. Changing epidemiology of malignant melanoma in Queensland. Med J Aust. 1980 Jan 26;1(2):66–69. [PubMed] [Google Scholar]
  12. MacKie R., Hunter J. A., Aitchison T. C., Hole D., Mclaren K., Rankin R., Blessing K., Evans A. T., Hutcheon A. W., Jones D. H. Cutaneous malignant melanoma, Scotland, 1979-89. The Scottish Melanoma Group. Lancet. 1992 Apr 18;339(8799):971–975. doi: 10.1016/0140-6736(92)91539-k. [DOI] [PubMed] [Google Scholar]
  13. Mattsson B., Wallgren A. Completeness of the Swedish Cancer Register. Non-notified cancer cases recorded on death certificates in 1978. Acta Radiol Oncol. 1984;23(5):305–313. doi: 10.3109/02841868409136026. [DOI] [PubMed] [Google Scholar]
  14. McGregor S. E., Birdsell J. M., Grace M. A., Jerry L. M., Hill G. B., Paterson A. H., McPherson T. A. Cutaneous malignant melanoma in Alberta: 1967-1976. Cancer. 1983 Aug 15;52(4):755–761. doi: 10.1002/1097-0142(19830815)52:4<755::aid-cncr2820520433>3.0.co;2-q. [DOI] [PubMed] [Google Scholar]
  15. Osterlind A., Møller Jensen O. Trends in incidence of malignant melanoma of the skin in Denmark 1943-1982. Recent Results Cancer Res. 1986;102:8–17. doi: 10.1007/978-3-642-82641-2_2. [DOI] [PubMed] [Google Scholar]
  16. Osterlind A., Tucker M. A., Hou-Jensen K., Stone B. J., Engholm G., Jensen O. M. The Danish case-control study of cutaneous malignant melanoma. I. Importance of host factors. Int J Cancer. 1988 Aug 15;42(2):200–206. doi: 10.1002/ijc.2910420210. [DOI] [PubMed] [Google Scholar]
  17. Osterlind A., Tucker M. A., Stone B. J., Jensen O. M. The Danish case-control study of cutaneous malignant melanoma. II. Importance of UV-light exposure. Int J Cancer. 1988 Sep 15;42(3):319–324. doi: 10.1002/ijc.2910420303. [DOI] [PubMed] [Google Scholar]
  18. Philipp R., Hastings A., Briggs J., Sizer J. Are malignant melanoma time trends explained by changes in histopathological criteria for classifying pigmented skin lesions? J Epidemiol Community Health. 1988 Mar;42(1):14–16. doi: 10.1136/jech.42.1.14. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Shafir R., Hiss J., Tsur H., Bubis J. J. The thin malignant melanoma: changing patterns of epidemiology and treatment. Cancer. 1982 Aug 15;50(4):817–819. doi: 10.1002/1097-0142(19820815)50:4<817::aid-cncr2820500434>3.0.co;2-v. [DOI] [PubMed] [Google Scholar]
  20. Thörn M., Adami H. O., Bergström R., Ringborg U., Krusemo U. B. Trends in survival from malignant melanoma: remarkable improvement in 23 years. J Natl Cancer Inst. 1989 Apr 19;81(8):611–617. doi: 10.1093/jnci/81.8.611. [DOI] [PubMed] [Google Scholar]
  21. Thörn M., Adami H. O., Ringborg U., Bergström R., Krusemo U. The association between anatomic site and survival in malignant melanoma. An analysis of 12,353 cases from the Swedish Cancer Registry. Eur J Cancer Clin Oncol. 1989 Mar;25(3):483–491. doi: 10.1016/0277-5379(89)90261-7. [DOI] [PubMed] [Google Scholar]
  22. Thörn M., Bergström R., Adami H. O., Ringborg U. Trends in the incidence of malignant melanoma in Sweden, by anatomic site, 1960-1984. Am J Epidemiol. 1990 Dec;132(6):1066–1077. doi: 10.1093/oxfordjournals.aje.a115749. [DOI] [PubMed] [Google Scholar]
  23. Thörn M., Pontén F., Bergström R., Sparén P., Adami H. O. Clinical and histopathologic predictors of survival in patients with malignant melanoma: a population-based study in Sweden. J Natl Cancer Inst. 1994 May 18;86(10):761–769. doi: 10.1093/jnci/86.10.761. [DOI] [PubMed] [Google Scholar]
  24. Thörn M., Sparén P., Bergström R., Adami H. O. Trends in mortality rates from malignant melanoma in Sweden 1953-1987 and forecasts up to 2007. Br J Cancer. 1992 Sep;66(3):563–567. doi: 10.1038/bjc.1992.315. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. van der Esch E. P., Muir C. S., Nectoux J., Macfarlane G., Maisonneuve P., Bharucha H., Briggs J., Cooke R. A., Dempster A. G., Essex W. B. Temporal change in diagnostic criteria as a cause of the increase of malignant melanoma over time is unlikely. Int J Cancer. 1991 Feb 20;47(4):483–489. doi: 10.1002/ijc.2910470402. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES